Janumet XR 100-1,000 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26FE7B6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,331
Award facts
- Contract value 100% obligated
- $16,330.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Janumet XR 100-1,000 mg tablets (90-count units) with a ceiling value of $16,330.70. This firm fixed-price delivery order, with an ultimate completion date of November 19, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceuticals and medical supplies to military healthcare programs worldwide.
This award reflects AmerisourceBergen's established role as a critical vendor within the federal medical supply chain, particularly for the Defense Health Agency and military healthcare systems. Janumet XR is a diabetes medication combining sitagliptin and metformin, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains including endocrinology treatments. The relatively short completion timeline and firm fixed-price structure are typical of routine pharmaceutical replenishment orders issued through the company's prime indefinite delivery vehicle, demonstrating the operational efficiency of the DLA's pharmaceutical procurement process.
Quick answers
Who was awarded contract SPE2DR26FE7B6?
SPE2DR26FE7B6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FE7B6 worth?
The government has obligated $16,331 on SPE2DR26FE7B6.
Is contract SPE2DR26FE7B6 an order under another contract?
Yes. SPE2DR26FE7B6 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FE7B6 competed?
The extent of competition for SPE2DR26FE7B6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award